Fyn-Head Tablet
189,00 ₹
Аналоги Fyn-Head Tablet
Знайдіть доступніші аналоги та дженерики для Fyn-Head Tablet.
Активний інгредієнт: Sumatriptan; Naproxen
Опис товару
About Fyn-Head Tablet
Fyn-Head Tablet is a medication containing the active ingredient Sumatriptan, classified as Medication used for migraines & cluster headaches. Sumatriptan, sold under the brand name Imitrex among others, is a medication used to treat migraine headaches and cluster headaches. It is taken orally, intranasally, or by subcutaneous injection. Therapeutic effects generally occur within three hours. Sumatriptan is a serotonin (5-HT1B/1D) receptor agonist (triptan).
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE Sumatriptan Injection, USP is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the.
- Used for: Limitations of Use: • Use only if a clear diagnosis of migraine or cluster headache has been established
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
Sumatriptan, the active ingredient in Fyn-Head Tablet, belongs to the Medication used for migraines & cluster headaches class. 1 INDICATIONS AND USAGE Sumatriptan Injection, USP is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache. Limitations of Use: • Use only if a clear diagnosis of migraine or cluster headache has been established. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking Fyn-Head Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Fyn-Head Tablet for extended periods without medical advice.
Знайти в аптеках
Порівняйте місцеві ціни та відстань для Fyn-Head Tablet.
Оцінки відвідувачів
Допоможіть іншим — оцініть корисність цієї сторінки.
Оцінок ще немає — будьте першим.